EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phenotypic Alterations of CD8+ and CD8− CD56+ NK Cell Subsets in Moderate and Severe COVID‐19 Disease

Matyas Meggyes iD, David U Nagy iD, Ildiko Toth, Livia Mezosi, David Sipos, Agnes Peterfalvi iD, Laszlo Szereday iD

Journal of Immunology Research · 2026

DOI: 10.1155/jimr/8647361 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunology Research, 2026. Verfasst von Matyas Meggyes und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Medical School, University of Pecs, Pecs 7624, Hungary, pte.hu. Hauptthemen laut MEDLINE: COVID-19, Killer Cells, Natural, SARS-CoV-2, CD8-Positive T-Lymphocytes. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Pecs Medical School Research Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID‐19 pandemic has created a global health challenge. Severe cases are associated with immune system dysfunction, which can lead to uncontrolled inflammation. There are no published data on the specific roles of natural killer (NK)‐cell subsets and immune checkpoint (IC) molecules in disease severity. Thirty‐five patients diagnosed with COVID‐19 and 14 healthy controls were involved in the study. From peripheral blood, CD56dim and CD56bright cell subsets were analyzed by flow cytometry for the expression of IC molecules (T‐cell immunoglobulin and ITIM domain [TIGIT], CD226, and PD‐1), activation markers (CD69), and cytotoxic potential (CD107a degranulation, granzymes, and perforin content). In COVID‐19 patients, the proportion of CD8− CD56dim cells was significantly higher than the CD8+ subset. Inhibitory receptors TIGIT and PD‐1 exhibited significantly higher relative expression in CD8+ CD56dim cells compared to their CD8− counterparts across infected groups, an effect particularly pronounced in deceased patients. Conversely, activating CD226 expression was reduced in the CD8− CD56dim subset only in severe cases. Functional assays revealed significantly elevated CD107a and CD69 expression in CD56dim cells of patients versus controls. Notably, CD8− CD56bright cells from deceased patients demonstrated enhanced CD107a expression and elevated perforin content, suggesting a shift toward hyperactivation. The preferential upregulation of inhibitory checkpoint molecules on the highly active CD8+ subset may reflect a compensatory response to immune activation, whereas the enhanced activation of CD8− NK‐cell subsets was associated with disease severity and mortality. Similarly, the heightened cytotoxic profile of CD8− CD56bright cells observed in fatal cases may reflect immune dysregulation associated with severe COVID‐19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Killer Cells, NaturalSARS-CoV-2CD8-Positive T-LymphocytesHumansFemaleMaleCD56 AntigenMiddle AgedAgedAdultSeverity of Illness IndexReceptors, ImmunologicAntigens, CDAntigens, Differentiation, T-LymphocyteT Lineage-Specific Activation Antigen 1Programmed Cell Death 1 ReceptorPhenotype

Stichwörter der Autor:innen

CD107aCD8COVID-19NK cellsSARS-Cov-2immune checkpoints

Substanzen

CD56 AntigenReceptors, ImmunologicAntigens, CDNCAM1 protein, humanAntigens, Differentiation, T-LymphocyteT Lineage-Specific Activation Antigen 1Programmed Cell Death 1 ReceptorTIGIT protein, humanPDCD1 protein, human

Autor:innen und Institutionen

  • Department of Medical Microbiology, Medical School, University of Pecs, Pecs 7624, Hungary, pte.hu.
  • Institute for Ecology, Evolution and Diversity, Faculty of Biological Sciences, Goethe University Frankfurt, Frankfurt am Main, Germany, goethe-university-frankfurt.de.
  • Department of Anesthesiology and Intensive Therapy, Medical School, University of Pecs, Pecs 7624, Hungary, pte.hu.
  • 1st Department of Medicine, Division of Infectious Diseases, Medical School, University of Pecs, Pecs 7624, Hungary, pte.hu.
  • Department of Laboratory Medicine, Medical School, University of Pecs, Pecs 7624, Hungary, pte.hu.

ORCID-Profile: Matyas Meggyes, David U Nagy, Agnes Peterfalvi, Laszlo Szereday

Förderung

  • University of Pecs Medical School Research Grant

Zitieren

APA

Meggyes, M., Nagy, D. U., Toth, I., Mezosi, L., Sipos, D., Peterfalvi, A., & Szereday, L. (2026). Phenotypic Alterations of CD8+ and CD8− CD56+ NK Cell Subsets in Moderate and Severe COVID‐19 Disease. Journal of Immunology Research. https://doi.org/10.1155/jimr/8647361

Vancouver

Meggyes M, Nagy DU, Toth I, Mezosi L, Sipos D, Peterfalvi A, et al. Phenotypic Alterations of CD8+ and CD8− CD56+ NK Cell Subsets in Moderate and Severe COVID‐19 Disease. Journal of Immunology Research. 2026. doi:10.1155/jimr/8647361

BibTeX
@article{Meggyes2026,
  author = {Meggyes, Matyas and Nagy, David U and Toth, Ildiko and Mezosi, Livia and Sipos, David and Peterfalvi, Agnes and Szereday, Laszlo},
  title = {Phenotypic Alterations of CD8+ and CD8− CD56+ NK Cell Subsets in Moderate and Severe COVID‐19 Disease},
  journal = {Journal of Immunology Research},
  year = {2026},
  doi = {10.1155/jimr/8647361}
}
Kostenlos starten →